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Synthesis and in vitro bioactivity evaluation of new glucose and xylitol ester derivatives 
of 5- aminosalicylic acid 
ABSTRACT 
New glucose and xylitol esters of 5-amino salicylic acid (5-ASA) were synthesized followed 
by evaluation of their in vitro antimicrobial, anti-cancer and anti-inflammatory activities. The 
results of the antimicrobial activity assessment revealed that the new final esters were more 
effective against Gram-negative as well as Gram-positive bacteria than the original drug. 
Furthermore, the new final products were confirmed by a cytotoxicity assay over HT-29 and 
3T3 cell lines to be less toxic for normal cells compared to the initial drug. On the other hand, 
however, their suppressive effect against cancerous cells was somewhat lower. Meanwhile, 
the anti-inflammatory activity assay over a RAW264.7 macrophage cell line demonstrated 
that the NO inhibition activity of the conjugated drug to the previously mentioned 
saccharides, especially to glucose, has slightly improved compared to the non-conjugated 
drug. Finally, in silico screening was also performed in order to predict the potential 
interactions and binding energy of the novel products against cyclooxygenase (COX-1/COX-
2) and lipoxygenase (5-LOX) proteins. Findings indicated that the new products had greater 
hydrogen bonds and binding affinities with the active sites of proteins towards 5-ASA. 
